Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 427

1.

The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.

Aslan K, Meydanli MM, Oz M, Tohma YA, Haberal A, Ayhan A.

J Gynecol Oncol. 2020 Jan;31(1):e1. doi: 10.3802/jgo.2020.31.e1. Epub 2019 Jun 24.

2.

Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease.

Dannenberg L, Metzen D, Zako S, Pöhl M, Mourikis P, Helten C, Trojovsky K, Naguib D, Konsek D, Knoop B, Ayhan A, Hohlfeld T, Petzold T, Levkau B, Veulemans V, Zeus T, Kelm M, Polzin A.

Pharmacology. 2019 Oct 22:1-5. doi: 10.1159/000503582. [Epub ahead of print]

PMID:
31639801
3.

Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma.

Yorgancı A, Meydanlı MM, Kadıoğlu N, Taşkın S, Kayıkçıoğlu F, Altın D, Atasoy L, Haberal AN, Kınay T, Akgül MA, Tapısız ÖL, Evliyaoğlu Ö, Tekin ÖM, Fırat Ortaç U, Ayhan A.

J Gynecol Obstet Hum Reprod. 2019 Sep 6:101631. doi: 10.1016/j.jogoh.2019.101631. [Epub ahead of print] No abstract available.

PMID:
31499285
4.

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.

Yu Y, Suryo Rahmanto Y, Shen YA, Ardighieri L, Davidson B, Gaillard S, Ayhan A, Shi X, Xuan J, Wang TL, Shih IM.

EBioMedicine. 2019 Sep;47:184-194. doi: 10.1016/j.ebiom.2019.08.055. Epub 2019 Sep 3.

5.

Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.

Gurkan D, Ceren Akin A, Sahin H, Aytac Tohma Y, Sahin EA, Gunakan E, Iflazoglu N, Nihan Haberal A, Ayhan A.

J Obstet Gynaecol. 2019 Sep 4:1-7. doi: 10.1080/01443615.2019.1634028. [Epub ahead of print]

PMID:
31482736
6.

SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.

Kahramanoglu I, Meydanli MM, Taranenka S, Ayhan A, Salman C, Sanci M, Demirkiran F, Ortac F, Haidopoulos D, Sukhin V, Kaidarova D, Stepanyan A, Farazaneh F, Aliyev S, Ulrikh E, Kurdiani D, Yalcin İ, Mavrichev S, Akilli H, Sarı ME, Pletnev A, Aslan K, Bese T, Kairbayev M, Vlachos D, Gultekin M.

Int J Gynecol Cancer. 2019 Oct;29(8):1271-1279. doi: 10.1136/ijgc-2019-000643. Epub 2019 Sep 2.

PMID:
31481453
7.

Comparison of survival outcomes in optimally and maximally cytoreduced stage IIIC ovarian high-grade serous carcinoma: Women with only peritoneal tumor burden versus women with both peritoneal and lymphogenous dissemination.

Selcuk I, Meydanli MM, Yalcin I, Gungorduk K, Akgol S, Çelik H, Ayhan A.

J Obstet Gynaecol Res. 2019 Oct;45(10):2074-2081. doi: 10.1111/jog.14075. Epub 2019 Aug 1.

PMID:
31373110
8.

Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?

Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:209-214. doi: 10.1016/j.ejogrb.2019.07.002. Epub 2019 Jul 6.

PMID:
31325847
9.

Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.

Ayhan A, Aslan K, Öz M, Tohma YA, Kuşçu E, Meydanli MM.

Arch Gynecol Obstet. 2019 Sep;300(3):675-682. doi: 10.1007/s00404-019-05232-7. Epub 2019 Jul 1.

PMID:
31263988
10.

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy.

Park Y, Chui MH, Suryo Rahmanto Y, Yu ZC, Shamanna RA, Bellani MA, Gaillard S, Ayhan A, Viswanathan A, Seidman MM, Franco S, Leung AKL, Bohr VA, Shih IM, Wang TL.

Clin Cancer Res. 2019 Sep 15;25(18):5584-5594. doi: 10.1158/1078-0432.CCR-18-4222. Epub 2019 Jun 13.

PMID:
31196855
11.

Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.

Şahin H, Karatas F, Coban G, Özen Ö, Erdem Ö, Onan MA, Ayhan A.

J Gynecol Oncol. 2019 Jul;30(4):e54. doi: 10.3802/jgo.2019.30.e54. Epub 2019 Feb 4.

12.
13.

A novel prediction method for lymph node involvement in endometrial cancer: machine learning.

Günakan E, Atan S, Haberal AN, Küçükyıldız İA, Gökçe E, Ayhan A.

Int J Gynecol Cancer. 2019 Feb;29(2):320-324. doi: 10.1136/ijgc-2018-000033. Epub 2018 Dec 28.

PMID:
30718313
14.

Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.

Ayhan A, Şahin H, Sari ME, Yalçin I, Haberal A, Meydanli MM.

Int J Gynecol Cancer. 2019 Mar;29(3):505-512. doi: 10.1136/ijgc-2018-000069. Epub 2019 Jan 21.

PMID:
30665899
15.

Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.

Sahin H, Meydanli MM, Sari ME, Kocaman E, Cuylan ZF, Yalcin I, Coban G, Özen Ö, Sirvan L, Güngör T, Ayhan A.

Taiwan J Obstet Gynecol. 2019 Jan;58(1):82-89. doi: 10.1016/j.tjog.2018.11.016.

16.

Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.

Sarı ME, Meydanlı MM, Yalçın I, Şahin H, Çoban G, Çelik H, Kuşçu E, Gungor T, Ayhan A.

Oncol Res Treat. 2018;41(12):750-754. doi: 10.1159/000492585. Epub 2018 Nov 13.

17.

Comparison of stage III mucinous and serous ovarian cancer: a case-control study.

Firat Cuylan Z, Karabuk E, Oz M, Turan AT, Meydanli MM, Taskin S, Sari ME, Sahin H, Ulukent SC, Akbayir O, Gungorduk K, Gungor T, Kose MF, Ayhan A.

J Ovarian Res. 2018 Oct 30;11(1):91. doi: 10.1186/s13048-018-0464-2.

18.

Oncological and obstetric outcomes after fertility-sparing radical abdominal trachelectomy for early stage cervical cancer: a tertiary centre's 10 years' experience.

Ayhan A, Tohma YA, Sahin H, Kocaman E, Tunc M, Haberal AN.

J Obstet Gynaecol. 2019 Feb;39(2):248-252. doi: 10.1080/01443615.2018.1498830. Epub 2018 Oct 27.

PMID:
30371139
19.

The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?

Ayhan A, Akilli H, Haberal N.

Arch Gynecol Obstet. 2019 Jan;299(1):217-222. doi: 10.1007/s00404-018-4935-x. Epub 2018 Oct 12.

PMID:
30315413
20.

Bilateral synchronous ovarian tumours: an uncommon case and review of the literature.

Günakan E, Tohma YA, Haberal AN, Ayhan A.

Prz Menopauzalny. 2018 Jun;17(2):97-100. doi: 10.5114/pm.2018.77312. Epub 2018 Jun 30.

Supplemental Content

Loading ...
Support Center